Please use this identifier to cite or link to this item: http://repository.futminna.edu.ng:8080/jspui/handle/123456789/7244
Full metadata record
DC FieldValueLanguage
dc.contributor.authorFaruk Adamu Kuta-
dc.contributor.authorAudu Stella Ladidi-
dc.contributor.authorGarba Salami Alimi-
dc.contributor.authorAbdulameen Saheed Adedeji-
dc.date.accessioned2021-07-07T23:14:47Z-
dc.date.available2021-07-07T23:14:47Z-
dc.date.issued2016-
dc.identifier.citationKuta, F. A., Audu, S. L., Garba, S. A., & Adedeji, A.S. (2016). The Ebola Virus Disease in Africa. Journal of Science, Technology, Mathematics and Education (JOSTMED), 12(2), 10-18.en_US
dc.identifier.urihttp://repository.futminna.edu.ng:8080/jspui/handle/123456789/7244-
dc.description.abstractEbola virus disease is one of the most deadly human viral diseases in the world, and is caused by the Ebola virus. The symptoms which include (fever, sore throat, muscle pains, headaches, nausea, vomiting and diarrhea), begins usually after infection 2 to 21days. The strains include the Zaire, Sudan, Ivory Coast, and Bundibugyo and Reston. The disease is zoonotic (affects human and non-human primate) and typically occurs in tropical regions. The most recent outbreak of Ebola disease occurred in the year 2014 in Liberia and spilled to Nigeria through late Patrick Sawyer at Lagos. The virus can be acquired upon contact with blood or body fluid of an infected human and animal. The Pathological effect of the virus on infected human is achieved through viral Protein (VP) produced by gene 35 of the virus. The protein interferes with the activation of interferon, a component of human body defenses, thereby hindering protective immune response. Diagnosis is by screening blood samples through ELISA and RTPCR for possible detection of the virus. There is no specific drug for the treatment of Ebola virus disease. Therefore, samples from suspected carriers should be handled with caution.en_US
dc.description.sponsorshipSelfen_US
dc.language.isoenen_US
dc.publisherJournal of Science, Technology, Mathematics and Education (JOSTMED)en_US
dc.relation.ispartofseries12;2-
dc.subjectEbola virusen_US
dc.subjectDiseaseen_US
dc.subjectInterferonen_US
dc.subjectviral Protein (VP)en_US
dc.subjectStrainsen_US
dc.titleThe Ebola Virus Disease in Africa.en_US
dc.typeArticleen_US
Appears in Collections:Microbiology

Files in This Item:
File Description SizeFormat 
Kuta et al._2016J.pdf357.39 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.